Connecting Cytokines for the benefit of patients

THE STORY

IT ALL STARTED WHEN…

in 2009 Erik Hack established the Inflammation Research Lab of the Departments of Rheumatology & Clinical Immunology and Dermatology/Allergology in the University Medical Center Utrecht (UMCU) and decided to focus its research on improving the therapeutic potential of interleukin 10 (IL-10).

Synerkine news

Latest news:

Synerkines

a novel class of therapeutics

 

Synerkine pharma

the company